Phospholemman Modulates the Gating of Cardiac L-Type Calcium Channels
- 7 April 2010
- journal article
- Published by Elsevier BV in Biophysical Journal
- Vol. 98 (7), 1149-1159
- https://doi.org/10.1016/j.bpj.2009.11.032
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- The Timothy syndrome mutation of cardiac CaV1.2 (L‐type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivationJournal Of Physiology-London, 2009
- Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+-K+-ATPaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of Ca V 1.2 L-type calcium channelsProceedings of the National Academy of Sciences of the United States of America, 2008
- Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Regulation of cardiac contractility: high time for FXYDAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca (V) 1.2) calcium channelsBritish Journal of Pharmacology, 2007
- Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: Effects of ranolazineHeart Rhythm, 2007
- Kinetic Properties of the Cardiac L-Type Ca2+ Channel and Its Role in Myocyte Electrophysiology: A Theoretical InvestigationBiophysical Journal, 2007
- Altered contractility and [Ca2+]ihomeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+exchangeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Mechanisms of calcium channel modulation by β-adrenergic agents and dihydropyridine calcium agonistsJournal of Molecular and Cellular Cardiology, 1986